WAY logo

WAYSTAR HOLDING CORP

WAYNASDAQ
πŸ† #1209 by market capEarnings Oct 27US Equity
$24.31β–Ό $0.38 (βˆ’1.58%)
Market closed Β· at close
1hβ€”
24hβ–Ό 1.6%
7dβ–² 4.0%
14dβ–Ό 1.0%
30dβ–² 5.5%
1yβ–Ό 29.6%
🏦Market Cap
$4.66B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+19.2%
Healthy
πŸ“ŠGross Margin
69.1%
High
πŸ’΅FCF Margin
20.4%
Strong
βš–οΈP/S Ratio
3.9x
Fair
Otter Score
54
Weak

Trading Snapshot

Day Range
$24.14 – $24.74
52-Week Range
$17.26 – $41.47
Volume
$2.65B
Avg Volume
$2.93B
Shares Outstanding
191.8M
Next Earnings
Sep 14, 2026

Fundamentals Snapshot

Annual Revenue
$1.10B
Last Q Revenue
$320M
P/E Ratio
35.1
P/S Ratio
3.9x
EPS (TTM)
$0.70
Dividend Yield
β€”

Why Investors Own WAY

  • βœ“High-growth profile β€” revenue up +37.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 61% gross margin and 15% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.10Bβ–² +39.3% YoY
Gross Margin (TTM)
61.4%β–² +1.5% YoY
Operating Income (TTM)
$225Mβ–² +39.3% YoY
Free Cash Flow (TTM)
$166Mβ–² +39.3% YoY

About WAYSTAR HOLDING CORP

Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
54/100

Analyst Price Target

β“˜
Average Target
$27.34
β–² +12.4% Upside
High Target$31.83
Low Target$21.50
Based on 15 analysts

Latest News & Updates